← SynDRA
FADROZOLE
SynDRA canonical compound SYN0000325 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | CYP19A1 |
| Mechanism of action | Aromatase inhibitor |
| Indication | breast cancer |
| Disease area | oncology |
All known targets
- CYP19A1
- CYP11B1
- CYP11B2
- Cyp11b2
Mechanisms of action (all sources)
- Aromatase inhibitor
- CYP19A1 INHIBITOR
- Cytochrome P450 19A1 inhibitor
- CYP11B1 INHIBITOR
- CYP11B2 INHIBITOR
Drug classes
- Antineoplastic Agents
- Antineoplastic Agents, Hormonal
- Aromatase Inhibitors
- Enzyme Inhibitors
- Estrogen Antagonists
- Hormone Antagonists
- Steroid Synthesis Inhibitors
Cross-references
Synonyms
- fadrozole hydrochloride
- fadrozole HCl
- fadrozole monohydrochloride
- CGS-16949A
- Fadrozol
- Fadrozole [INN]
- Fadrozolum [INN-Latin]
- Fadrozol [INN-Spanish]
- CHEMBL9298
- Fadrozole (INN)
- 5-p-cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine
- Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-
- Fadrozolum
- 4-{5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl}benzonitrile
- Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-
- 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile
- H3988M64PU
- CGS020286A
- 4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile
- 4-(5,6,7,8-tetrahydroimidazo(5,1-f)pyridin-5-yl)benzonitrile
- 4-(5,6,7,8-tetrahydroimidazo[5,1-f]pyridin-5-yl)benzonitrile
- FAD286
- CGS-020286A
- RefChem:597144
- DTXCID3014141
- CGS16949A
- FAD 286
- MFCD02313480
- FAD 286A
- UNII-H3988M64PU
- CCRIS 8823
- FADRAZOLE
- FADROZOLE [MI]
- FADROZOLE [WHO-DD]
- Fadrozole (CGS16949A)
- SCHEMBL25491
- MLS006010399
Look up FADROZOLE in the interactive SynDRA portal →